Related Experiment Video
Updated: Oct 1, 2025

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
Long Noncoding RNA lncNDEPD1 Regulates PD-1 Expression via miR-3619-5p in CD8+ T Cells
Shaoyan Cheng1, Feng Li1, Haiming Qin1
1Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China.
Abstract:
Therapies targeting programmed cell death protein 1 (PD-1) have gained great success in patients with multiple types of cancer. The regulatory mechanisms underlying PD-1 expression have been extensively explored. However, the impact of long noncoding RNAs on PD-1 expression remains elusive. In this study, we identified the Notch1/lncNDEPD1 axis, which plays a critical role in PD-1 expression in human CD8+ T cells. RNA sequencing and quantitative reverse transcription PCR data showed that lncNDEPD1 was upregulated in activated T cells, especially in PD-1high subsets. Fluorescence in situ hybridization demonstrated that lncNDEPD1 was localized in the cytoplasm. A mechanistic study showed that lncNDEPD1 could bind with miR-3619-5p and PDCD1 mRNA to prevent PDCD1 mRNA degradation and then upregulate PD-1 expression. A chromatin immunoprecipitation assay showed that Notch1 directly binds to the promoter of lncNDEPD1 instead of PDCD1 Furthermore, chimeric Ag receptor T cells expressing lncNDEPD1-specific short hairpin RNAs were generated. Chimeric Ag receptor T cells with decreased lncNDEPD1 expression showed enhanced tumoricidal effects when PD-L1 was present. Our work uncovered a new regulatory mechanism of PD-1 expression and thus provided a potential target to decrease PD-1 without affecting T cell function.
Insights
This study identifies a new pathway regulating programmed cell death protein 1 (PD-1) in T cells. The Notch1/lncNDEPD1 axis increases PD-1, offering a potential target to enhance cancer immunotherapy.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Programmed cell death protein 1 (PD-1) targeted therapies are effective in cancer treatment.
- Mechanisms regulating PD-1 expression are known, but the role of long noncoding RNAs is unclear.
Purpose of the Study:
- To investigate the role of long noncoding RNAs in PD-1 expression in human CD8+ T cells.
- To identify novel regulatory pathways of PD-1 expression.
Main Methods:
- RNA sequencing and quantitative reverse transcription PCR to analyze lncNDEPD1 expression.
- Fluorescence in situ hybridization for subcellular localization.
- Mechanistic studies involving RNA binding assays and chromatin immunoprecipitation.
- Generation of chimeric antigen receptor T cells with modified lncNDEPD1 expression.
Main Results:
- lncNDEPD1 is upregulated in activated T cells, particularly PD-1high subsets.
- lncNDEPD1 binds miR-3619-5p and PDCD1 mRNA, stabilizing PDCD1 mRNA and increasing PD-1 expression.
- Notch1 directly regulates lncNDEPD1 promoter activity.
- Reduced lncNDEPD1 expression in CAR T cells enhanced tumoricidal activity in the presence of PD-L1.
Conclusions:
- The Notch1/lncNDEPD1 axis is a novel regulator of PD-1 expression in CD8+ T cells.
- Targeting lncNDEPD1 may offer a strategy to enhance T cell-mediated anti-tumor immunity without compromising T cell function.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
09:36RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Abnormal Proliferation
Negative Regulator Molecules